In many diabetes cardiovascular outcome trials, average weight loss was relatively modest, yet the reduction in cardiovascular events was meaningful, suggesting additional biology at play beyond lighter body, healthier heart. 2) The timeline doesnt always match weight loss explains it all. Weight loss is a gradual process, but cardiovascular risk reduction can begin earlier than youd expect if weight loss were the only driver
Results from these tests should not replace professional medical advice or be interpreted without consulting a licensed practitioner familiar with your health history and needs
Bloating and food reactivity improvements tend to follow by week 4 to 6
Im the big guy that believes everyone is looking to make a buck at the expense of anyone else
Some research points to possible anti-inflammatory benefits, although this is still being studied
GLP-1 drugs, such as ozempic, were originally developed as a tool to help manage blood sugar among people with diabetes